Analysts’ Recommendations for Teva Pharmaceutical in June
Teva Pharmaceutical Industries (TEVA) has been in the news lately and is one of the most keenly watched stocks on Wall Street. Teva Pharmaceutical has reported positive developments with respect to its restructuring plan to restore its falling sales. On June 13, Reuters surveyed 29 analysts covering Teva.